DZ Bank
MYGN icon

DZ Bank’s Myriad Genetics MYGN Stock Holding History

DZ Bank’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-72,926
Closed -$2.15M – 1008
2018
Q1 		$2.15M Sell
72,926
-3,391
-4% -$115K 0.01% 540
2017
Q4 		$2.62M Sell
76,317
-57,412
-43% -$1.94M 0.01% 451
2017
Q3 		$4.84M Sell
133,729
-93,600
-41% -$2.67M 0.02% 378
2017
Q2 		$5.87M Hold
227,329
– – 0.03% 326
2017
Q1 		$4.36M Sell
227,329
-20,288
-8% -$359K 0.02% 367
2016
Q4 		$4.13M Buy
+247,617
New +$4.48M 0.02% 354

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DZ Bank's MYGN Position: Q2 2018 in Review

DZ Bank sold out of Myriad Genetics (MYGN) in Q2 2018, closing a stake of 72,926 shares — an estimated $2.15M sold.

DZ Bank first reported a position in MYGN in Q4 2016 and held it in 6 quarters. The position peaked at $5.87M in Q2 2017. 258 funds tracked by Wall St. Rank hold MYGN as of Q2 2018.

  • DZ Bank reported no remaining Myriad Genetics position as of Q2 2018 after selling out during the quarter.
  • DZ Bank sold 72,926 Myriad Genetics shares in Q2 2018, an estimated $2.15M.
  • DZ Bank first reported a position in Myriad Genetics in Q4 2016 and held it in 6 quarters.
  • DZ Bank's Myriad Genetics position peaked at $5.87M in Q2 2017.
  • 258 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.